OIS at AAO 2015

Amblyotech

Nov 12, 2015 12:40pm ‐ Nov 12, 2015 12:45pm


Description

Amblyotech is a hybrid life sciences/software development company focused on the treatment of ocular disorders, starting with Amblyopia. The company’s patented Binocuclear technology incorporates a dichoptic approach to the treatment of this condition. Using a dedicated electronic tablet, the company’s technology is delivered to the patient through a novel game technology.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content